Ventas, Inc. (NYSE:VTR) ("Ventas" or the "Company") today reported results for the first quarter ended March 31, 2022.

Highlights

Net Income Attributable to Common Stockholders ("Net Income") per share of $0.10

Normalized Funds from Operations* ("Normalized FFO") per share of $0.79, inclusive of the benefit of $33 million or 8 cents per share of HHS Grants received during the quarter and previously communicated

Total Company year-over-year same-store cash Net Operating Income* ("NOI") growth of 5.8% for the first quarter 2022, excluding the benefit of HHS Grants received

First quarter 2022 SHOP segment year-over-year same-store cash NOI* growth of 14.2%, excluding the benefit of HHS Grants received, at the high-end of the guidance range, driven by same-store revenue growth of nearly 10%

Approximately $500 million of closed or committed new investments year-to-date, principally in senior housing and life science, research & innovation

Second quarter 2022 guidance for Net Income per share of ($0.03) - $0.01, Normalized FFO* per share of $0.69 - $0.73 and year-over-year same-store cash NOI* growth in the SHOP segment of 2 - 10%

CEO Remarks

"We are pleased that we grew first quarter year-over-year Normalized FFO and SHOP same-store cash NOI for the first time since the pandemic began (excluding the benefit of HHS Grants in both periods). These strong results underscore the positive momentum of our high-quality portfolio and the powerful senior housing recovery now underway. Our SHOP communities benefitted from strong demand and pricing power during the quarter, demonstrating the strength, resiliency and potential of the assets, and overcoming inflationary impacts and the effects of COVID-19," said Debra A. Cafaro, Ventas Chairman and CEO.

"As we look to the second quarter of 2022, we are again projecting that our earnings will benefit from continued attractive year-over-year organic growth in our SHOP segment and contribution from investments in senior housing, life science and medical office over the last twelve months. Based on favorable supply and demand fundamentals, we continue to expect sustained improvement in SHOP same-store cash NOI through 2022. We believe that our steadfast focus on execution and the decisive actions we continue to take position us to drive superior and sustainable value for our shareholders," Cafaro concluded.

*	This is a non-GAAP financial measure. Refer to the Non-GAAP Financial Measures Reconciliation tables at the end of this press release for additional information and a reconciliation to the most directly comparable GAAP measure.

First Quarter 2022 Enterprise Results

(per share)
	Quarter Ended March 31,
	2022	2021	$ Change	% Change
Attributable Net Income (Loss)	$0.10	($0.15)	$0.25	n/a
Nareit FFO*	$0.81	$0.67	$0.14	21%
Normalized FFO*	$0.79	$0.72	$0.07	10%

*This is a non-GAAP financial measure. Refer to the Non-GAAP Financial Measures Reconciliation tables at the end of this press release for additional information and a reconciliation to the most directly comparable GAAP measure.

The above earnings measures include $32.8 million ($0.08 per share) benefit of HHS Grants (defined below) in the first quarter of 2022 and include $13.6 million ($0.04 per share) benefit of HHS Grants in the first quarter of 2021.

First Quarter 2022 Property Results

	1Q22 (Quarterly Pools) Year-Over-Year Same-Store Cash NOI* Growth
Business Segment	Assets	% Change	% Change (ex. HHS Grants)¹
SHOP	321	25.8%	14.2%
Triple-Net	331	0.6%	0.6%
Office	332	4.6%	4.6%
Total Company	984	9.5%	5.8%


*		This is a non-GAAP financial measure. Refer to the Non-GAAP Financial Measures Reconciliation tables at the end of this press release for additional information and a reconciliation to the most directly comparable GAAP measure.
¹		SHOP same-store growth adjusted to exclude the benefit of HHS Grants received to partially offset direct COVID-19 costs incurred by the Company to date. The HHS Grants are recorded as a contra expense within SHOP operating expenses, net of any applicable fees to SHOP operators. The quarterly pools include a ~$21.1M net benefit attributable to HHS Grants received in 1Q22 and a ~$7.6M net benefit attributable to HHS Grants received in 1Q21.

SHOP Portfolio (37% of Total Portfolio)

Excluding HHS Grants, SHOP year-over-year same-store cash NOI growth of 14.2% in the first quarter of 2022 was driven by continued robust demand, increased occupancy and pricing power, which outpaced inflationary expense pressures and the continuing impacts of COVID-19 in the quarter.

Clinical: Consistent with broader US trends, COVID-19 resident and staff confirmed cases increased sharply in January and February in Ventas's SHOP communities but have since declined.
Leading Indicators: Robust demand resulted in leads and move-ins consistently trending at over 100% of pre-pandemic levels in the quarter, outperforming typical seasonal patterns.
Revenue: In the first quarter, same-store revenue increased by nearly 10% versus the prior year due to the positive trends in occupancy and RevPOR.
- Same-store average occupancy grew year-over-year by 420 basis points to 83.0% in the first quarter 2022, ahead of the guidance midpoint of 410 basis points.
- Same-store RevPOR increased by 4.2% versus the prior year. RevPOR benefited from strong in-place resident rate increases approximating 8% in the first quarter 2022 in the U.S., and improving re-leasing spreads. Pricing for new residents continued to trend positively despite industry occupancy well below stabilized levels.
Excluding HHS Grants, same-store operating expenses grew 8% year-over-year, driven by macro inflationary impacts throughout the quarter on labor, utilities and other operating expenses.

Triple-Net Portfolio (31% of Total Portfolio)

Triple-Net year-over-year same-store cash NOI increased by 0.6%, driven by contractual escalators, partially offset by reduced payments from select senior housing tenants due to the continued pandemic impact.

Office Portfolio (30% of Total Portfolio)

Office year-over-year same-store cash NOI increased by 4.6%, driven by contractual escalators, strong leasing, collection of holdover rent and continued recovery in parking revenue.

Select Investment Activity

Year-to-date in 2022, the Company continued to grow its superior, well positioned portfolio by closing on or committing to approximately $500 million in relationship-driven investments, consistent with its priorities of investing in senior housing and life science, research & innovation:

Mangrove Bay: In February 2022, the Company closed on the previously announced acquisition of Mangrove Bay, a Class A senior housing community in the highly sought-after Jupiter, Florida market for $107 million at an attractive in-place yield of nearly 6%.

Le Groupe Maurice: Continuing its successful track record of development with its partner Le Groupe Maurice, Ventas announced that it expects to break ground on a new $90 million, 362-unit senior housing development project in the attractive Montreal, Quebec market.

3440 Market: Ventas expanded its presence and offerings to its tenants in the exciting uCity, Philadelphia submarket with the value-add acquisition and intended redevelopment of 3440 Market for $73 million, inclusive of redevelopment costs. Located adjacent to existing Ventas life science buildings, the expected yield after redevelopment is 7%.

Medical Office: The Company completed the previously announced acquisition of 18 MOBs comprising 732,000 square feet 100% leased to Ardent Health Services for a twelve-year term. The price was $204 million, reflecting a ~6% GAAP yield. Ventas also completed the $40 million acquisition of Eating Recovery Center, a Class-A behavioral health facility located in Denver, CO at a 6.6% GAAP yield. The asset is 100% net leased with 12 years remaining in the lease term.

Second Quarter 2022 Guidance

The Company currently expects to report second quarter 2022 Net Income (Loss) Attributable to Common Stockholders, Nareit FFO and Normalized FFO per share and same-store cash NOI growth within the following ranges:

	2Q22 Guidance
	Per Share
	Low		High

Net Income (Loss) Attributable to Common Stockholders	($0.03)	-	$0.01
Nareit FFO*	$0.66	-	$0.70
Normalized FFO*	$0.69	-	$0.73

	2Q22 Guidance: Same-Store Cash NOI Growth
	(vs. 2Q21, Quarterly Pools)
	Percentage Change
Business Segment	Low		High
SHOP¹	2.0%	-	10.0%
Triple-Net	(3.0%)	-	(1.5%)
Office	1.75%	-	2.25%
Total Company	0.0%	-	3.0%

*		This is a non-GAAP financial measure. Refer to the Non-GAAP Financial Measures Reconciliation tables at the end of this press release for additional information and a reconciliation to the most directly comparable GAAP measure.
¹		Excluding the benefit of HHS Grants in all periods.

Key assumptions underlying the second quarter 2022 guidance include:

SHOP: We anticipate approximately 10% year-over-year revenue growth at the midpoint of the same-store cash NOI guidance range driven by the expected combination of approximately 400 basis points of occupancy growth and improved rates. Revenue growth is expected to be partially offset by continued inflationary expense pressure, with the SHOP same-store cash NOI guidance range principally a function of operating expense assumptions.

Office: Same-store cash NOI growth is expected to be driven by contractual escalators, leasing and parking. As previously communicated, Normalized FFO will be reduced by ($0.01) per share sequentially due to the proposed redevelopment into high demand lab space at two R&I properties, following the move-out of two tenants enabling the contemplated projects.

Triple-Net: As previously communicated, Normalized FFO will be impacted by ($0.01) per share sequentially due to lease resolutions with senior housing triple-net tenants who were materially affected by the COVID-19 pandemic. Ventas expects to receive the benefit of upward future performance in these assets through revenue or NOI-based payments.

General and Administrative Expenses: We anticipate the Normalized FFO impact of second quarter general and administrative expenses to be approximately $34 million to $36 million.

Transactions: The guidance does not assume any new or unannounced material acquisitions or capital markets activities.

Dispositions: We expect disposition proceeds of $200 million principally in the second half of 2022.

Please see below for further discussion and our definitions of non-GAAP measures along with reconciliations to the most directly comparable GAAP measure. We will provide additional detail regarding our second quarter outlook and assumptions on the first quarter 2022 conference call.

Investor Presentation

A presentation outlining the Company's first quarter results, second quarter guidance and key assumptions, and a business update is posted to the Events & Presentations section of Ventas's website at ir.ventasreit.com/events-and-presentations. Additional information regarding the Company can be found in its first quarter 2022 supplemental posted at ir.ventasreit.com. The information contained on, or that may be accessed through, our website, including the information contained in the aforementioned presentation and supplemental, is not incorporated by any reference into, and is not part of, this document.

First Quarter 2022 Results Conference Call

Ventas will hold a conference call to discuss this earnings release on Friday, May 6, 2022 at 10:00 a.m. Eastern Time (9:00 a.m. Central Time).

The dial-in number for the conference call is (888) 330-3576 (or +1 (646) 960-0672 for international callers), and the participant passcode is 7655497. A live webcast can be accessed from the Investor Relations section of www.ventasreit.com.

A telephonic replay will be available at (800) 770-2030 (or +1 (647) 362-9199 for international callers), passcode 7655497, after the earnings call and will remain available for 30 days. The webcast replay will be posted in the Investor Relations section of www.ventasreit.com.

About Ventas

Ventas Inc., an S&P 500 company, operates at the intersection of two large and dynamic industries – healthcare and real estate. Fueled by powerful demographic demand from growth in the aging population, Ventas owns a diversified portfolio of over 1,200 properties in the United States, Canada, and the United Kingdom. Ventas uses the power of its capital to unlock the value of senior living communities; life science, research & innovation properties; medical office & outpatient facilities, hospitals and other healthcare real estate. A globally-recognized real estate investment trust, Ventas follows a successful long-term strategy, proven over more than 20 years, built on diversification of property types, capital sources and industry leading partners, financial strength and flexibility, consistent and reliable growth and industry leading ESG achievements, managed by a collaborative and experienced team dedicated to its stakeholders.

Non-GAAP Financial Measures

This press release includes certain financial performance measures not defined by generally accepted accounting principles in the United States ("GAAP"). Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP measures are included in this press release. We believe such measures provide investors with additional information concerning our operating performance and a basis to compare our performance with the performance of other REITs. Our definitions and calculations of these non-GAAP measures may not be the same as similar measures reported by other REITs.

These non-GAAP financial measures should not be considered as alternatives to net income attributable to common stockholders (determined in accordance with GAAP) as indicators of our financial performance, as alternatives to cash flow from operating activities (determined in accordance with GAAP), or as measures of our liquidity, nor are these measures necessarily indicative of sufficient cash flow to fund all of our needs.

Cautionary Statements

Certain of the information contained herein, including intra-quarter operating information and number of confirmed cases of COVID-19, has been provided by our operators and we have not verified this information through an independent investigation or otherwise. We have no reason to believe that this information is inaccurate in any material respect, but we cannot assure you of its accuracy.

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements include, among others, statements of expectations, beliefs, future plans and strategies, anticipated results from operations and developments and other matters that are not historical facts. Forward-looking statements include, among other things, statements regarding our and our officers' intent, belief or expectation as identified by the use of words such as "may," "will," "project," "expect," "believe," "intend," "anticipate," "seek," "target," "forecast," "plan," "potential," "opportunity," "estimate," "could," "would," "should" and other comparable and derivative terms or the negatives thereof.

Forward-looking statements are based on management's beliefs as well as on a number of assumptions concerning future events. You should not put undue reliance on these forward-looking statements, which are not a guarantee of performance and are subject to a number of uncertainties and other factors that could cause actual events or results to differ materially from those expressed or implied by the forward-looking statements. We do not undertake a duty to update these forward-looking statements, which speak only as of the date on which they are made. You are urged to carefully review the disclosures we make concerning risks and uncertainties that may affect our business and future financial performance, including those made below and in our filings with the Securities and Exchange Commission, such as in the section titled "Cautionary Statements — Summary Risk Factors," "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in the Company's Annual Report on Form 10-K for the year ended December 31, 2021 and Quarterly Report on Form 10-Q for the quarter ended March 31, 2022.

Certain factors that could affect our future results and our ability to achieve our stated goals include, but are not limited to: (a) the impact of the ongoing COVID-19 pandemic and its extended consequences, including of the Delta, Omicron or any other variant, on our revenue, level of profitability, liquidity and overall risk exposure and the implementation and impact of regulations related to the CARES Act and other stimulus legislation and any future COVID-19 relief measures; (b) our ability to achieve the anticipated benefits and synergies from, and effectively integrate, our acquisitions and investments, including our acquisition of New Senior Investment Group Inc.; (c) our exposure and the exposure of our tenants, managers and borrowers to complex healthcare and other regulation and the challenges and expense associated with complying with such regulation; (d) the potential for significant general and commercial claims, legal actions, regulatory proceedings or enforcement actions that could subject us or our tenants, managers or borrowers to increased operating costs and uninsured liabilities; (e) the impact of market and general economic conditions, including economic and financial market events, inflation, changes in interest rates, supply chain pressures, events that affect consumer confidence, our occupancy rates and resident fee revenues, and the actual and perceived state of the real estate markets, labor markets and public capital markets; (f) our ability, and the ability of our tenants, managers and borrowers, to navigate the trends impacting our or their businesses and the industries in which we or they operate; (g) the risk of bankruptcy, insolvency or financial deterioration of our tenants, managers, borrowers and other obligors and our ability to foreclose successfully on the collateral securing our loans and other investments in the event of a borrower default; (h) our ability to identify and consummate future investments in or dispositions of healthcare assets and effectively manage our portfolio opportunities and our investments in co-investment vehicles, joint ventures and minority interests; (i) risks related to development, redevelopment and construction projects; (j) our ability to attract and retain talented employees; (k) the limitations and significant requirements imposed upon our business as a result of our status as a REIT and the adverse consequences (including the possible loss of our status as a REIT) that would result if we are not able to comply; (l) the risk of changes in healthcare law or regulation or in tax laws, guidance and interpretations, particularly as applied to REITs, that could adversely affect us or our tenants, managers or borrowers; (m) increases in our borrowing costs as a result of becoming more leveraged or as a result of changes in interest rates and phasing out of LIBOR rates; (n) our reliance on third parties to operate a majority of our assets and our limited control and influence over such operations and results; (o) our dependency on a limited number of tenants and managers for a significant portion of our revenues and operating income; (p) the adequacy of insurance coverage provided by our policies and policies maintained by our tenants, managers or other counterparties; (q) the occurrence of cyber incidents that could disrupt our operations, result in the loss of confidential information or damage our business relationships and reputation; (r) the impact of merger, acquisition and investment activity in the healthcare industry or otherwise affecting our tenants, managers or borrowers; (s) disruptions to the management and operations of our business and the uncertainties caused by activist investors; and (t) the risk of catastrophic or extreme weather and other natural events and the physical effects of climate change.

CONSOLIDATED BALANCE SHEETS
(In thousands, except per share amounts; dollars in USD)
(unaudited)

	March 31,			December 31,			September 30,			June 30,			March 31,
		2022			2021			2021			2021			2021
Assets
Real estate investments:
Land and improvements	$	2,452,474		$	2,432,065		$	2,395,751		$	2,231,836		$	2,235,773
Buildings and improvements		26,186,628			25,778,490			25,519,840			24,269,450			24,250,630
Construction in progress		275,896			269,315			298,982			288,910			310,547
Acquired lease intangibles		1,373,364			1,369,747			1,372,462			1,200,574			1,212,263
Operating lease assets		318,679			317,858			323,950			328,707			343,072
		30,607,041			30,167,475			29,910,985			28,319,477			28,352,285
Accumulated depreciation and amortization		(8,624,820	)		(8,350,637	)		(8,118,990	)		(8,189,447	)		(8,030,524	)
Net real estate property		21,982,221			21,816,838			21,791,995			20,130,030			20,321,761
Secured loans receivable and investments, net		530,388			530,126			530,439			596,171			615,037
Investments in unconsolidated real estate entities		541,914			523,465			507,880			494,239			471,243
Net real estate investments		23,054,523			22,870,429			22,830,314			21,220,440			21,408,041
Cash and cash equivalents		149,599			149,725			143,770			233,837			169,661
Escrow deposits and restricted cash		49,848			46,872			52,752			40,931			40,551
Goodwill		1,045,663			1,046,140			1,046,070			1,051,832			1,051,780
Assets held for sale		26,231			28,399			316,769			90,002			59,860
Deferred income tax assets, net		11,152			11,152			11,496			11,486			11,610
Other assets		613,091			565,069			643,253			855,786			810,760
Total assets	$	24,950,107		$	24,717,786		$	25,044,424		$	23,504,314		$	23,552,263
Liabilities and equity
Liabilities:
Senior notes payable and other debt	$	12,413,743		$	12,027,544		$	12,078,835		$	11,761,545		$	11,759,299
Accrued interest		93,564			106,602			90,013			105,883			91,390
Operating lease liabilities		195,668			197,234			199,551			205,484			206,426
Accounts payable and other liabilities		1,079,596			1,090,254			1,142,822			1,122,171			1,109,279
Liabilities related to assets held for sale		8,411			10,850			20,518			4,568			3,853
Deferred income tax liabilities		52,750			59,259			65,196			68,097			65,777
Total liabilities		13,843,732			13,491,743			13,596,935			13,267,748			13,236,024
Redeemable OP unitholder and noncontrolling interests		313,685			280,283			280,344			252,662			244,619
Commitments and contingencies
Equity:
Ventas stockholders' equity:
Preferred stock, $1.00 par value; 10,000 shares authorized, unissued		—			—			—			—			—
Common stock, $0.25 par value; 399,623; 399,420; 399,177; 375,204 and 375,068 shares issued at March 31, 2022, December 31, 2021, September 30, 2021, June 30, 2021 and March 31, 2021, respectively		99,888			99,838			99,777			93,784			93,750
Capital in excess of par value		15,478,467			15,498,956			15,504,210			14,187,577			14,186,692
Accumulated other comprehensive loss		(59,296	)		(64,520	)		(67,601	)		(58,290	)		(52,497	)
Retained earnings (deficit)		(4,821,653	)		(4,679,889	)		(4,459,630	)		(4,340,052	)		(4,257,001	)
Treasury stock, 0; 0; 1; 6 and 14 shares issued at March 31, 2022, December 31, 2021, September 30, 2021, June 30, 2021 and March 31, 2021, respectively		—			—			(40	)		(320	)		(789	)
Total Ventas stockholders' equity		10,697,406			10,854,385			11,076,716			9,882,699			9,970,155
Noncontrolling interests		95,284			91,375			90,429			101,205			101,465
Total equity		10,792,690			10,945,760			11,167,145			9,983,904			10,071,620
Total liabilities and equity	$	24,950,107		$	24,717,786		$	25,044,424		$	23,504,314		$	23,552,263

CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except per share amounts; dollars in USD)
(unaudited)

	For the Three Months Ended March 31,
		2022			2021
Revenues
Rental income:
Triple-net leased	$	151,561		$	159,885
Office		200,540			197,455
		352,101			357,340
Resident fees and services		651,121			528,650
Office building and other services revenue		3,949			4,950
Income from loans and investments		9,847			19,010
Interest and other income		536			341
Total revenues		1,017,554			910,291
Expenses
Interest		110,794			110,767
Depreciation and amortization		289,064			314,148
Property-level operating expenses:
Senior living		475,530			417,829
Office		63,183			63,946
Triple-net leased		4,008			4,825
		542,721			486,600
Office building and other services costs		1,313			618
General, administrative and professional fees		42,998			40,309
Loss on extinguishment of debt, net		—			27,090
Transaction expenses and deal costs		19,992			4,617
Allowance on loans receivable and investments		(54	)		(8,902	)
Other		(27,190	)		(9,428	)
Total expenses		979,638			965,819
Income (loss) before unconsolidated entities, real estate dispositions, income taxes and noncontrolling interests		37,916			(55,528	)
Loss from unconsolidated entities		(4,269	)		(250	)
Gain on real estate dispositions		2,455			2,533
Income tax benefit (expense)		4,490			(2,153	)
Income (loss) from continuing operations		40,592			(55,398	)
Net income (loss)		40,592			(55,398	)
Net income attributable to noncontrolling interests		1,860			1,811
Net income (loss) attributable to common stockholders	$	38,732		$	(57,209	)
Earnings per common share
Basic:
Income (loss) from continuing operations	$	0.10		$	(0.15	)
Net income (loss) attributable to common stockholders		0.10			(0.15	)
Diluted:¹
Income (loss) from continuing operations	$	0.10		$	(0.15	)
Net income (loss) attributable to common stockholders		0.10			(0.15	)
Weighted average shares used in computing earnings per common share
Basic		399,297			374,669
Diluted		403,260			377,922

Potential common shares are not included in the computation of diluted earnings per share when a loss from continuing operations exists as the effect would be an antidilutive per share amount.

QUARTERLY CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except per share amounts; dollars in USD)
(unaudited)

	For the Three Months Ended
	March 31,			December 31,			September 30,			June 30,			March 31,
		2022			2021			2021			2021			2021
Revenues
Rental income:
Triple-net leased	$	151,561		$	153,336		$	181,379		$	159,223		$	159,885
Office		200,540			194,781			201,673			200,388			197,455
		352,101			348,117			383,052			359,611			357,340
Resident fees and services		651,121			647,360			558,039			535,952			528,650
Office building and other services revenue		3,949			3,924			5,841			5,381			4,950
Income from loans and investments		9,847			9,577			28,729			17,665			19,010
Interest and other income		536			13,466			417			585			341
Total revenues		1,017,554			1,022,444			976,078			919,194			910,291
Expenses
Interest		110,794			110,455			108,816			110,051			110,767
Depreciation and amortization		289,064			318,959			313,596			250,700			314,148
Property-level operating expenses:
Senior living		475,530			515,427			453,659			424,813			417,829
Office		63,183			61,704			66,401			64,950			63,946
Triple-net leased		4,008			2,810			3,268			4,432			4,825
		542,721			579,941			523,328			494,195			486,600
Office building and other services costs		1,313			2,635			522			658			618
General, administrative and professional fees		42,998			28,602			30,259			30,588			40,309
Loss (gain) on extinguishment of debt, net		—			2,491			29,792			(74	)		27,090
Transaction expenses and deal costs		19,992			19,318			22,662			721			4,617
Allowance on loans receivable and investments		(54	)		(61	)		(60	)		(59	)		(8,902	)
Other		(27,190	)		26,355			33,673			(13,490	)		(9,428	)
Total expenses		979,638			1,088,695			1,062,588			873,290			965,819
Income (loss) before unconsolidated entities, real estate dispositions, income taxes and noncontrolling interests		37,916			(66,251	)		(86,510	)		45,904			(55,528	)
(Loss) income from unconsolidated entities		(4,269	)		(2,306	)		2,772			4,767			(250	)
Gain on real estate dispositions		2,455			24,705			150,292			41,258			2,533
Income tax benefit (expense)		4,490			4,747			(3,780	)		(3,641	)		(2,153	)
Income (loss) from continuing operations		40,592			(39,105	)		62,774			88,288			(55,398	)
Net income (loss)		40,592			(39,105	)		62,774			88,288			(55,398	)
Net income attributable to noncontrolling interests		1,860			1,749			2,094			1,897			1,811
Net income (loss) attributable to common stockholders	$	38,732		$	(40,854	)	$	60,680		$	86,391		$	(57,209	)
Earnings per common share
Basic:
Income (loss) from continuing operations	$	0.10		$	(0.10	)	$	0.16		$	0.24		$	(0.15	)
Net income (loss) attributable to common stockholders		0.10			(0.10	)		0.16			0.23			(0.15	)
Diluted:¹
Income (loss) from continuing operations	$	0.10		$	(0.10	)	$	0.16		$	0.23		$	(0.15	)
Net income (loss) attributable to common stockholders		0.10			(0.10	)		0.16			0.23			(0.15	)
Weighted average shares used in computing earnings per common share
Basic		399,297			399,142			381,996			375,067			374,669
Diluted		403,260			403,108			385,523			378,408			377,922

Potential common shares are not included in the computation of diluted earnings per share when a loss from continuing operations exists as the effect would be an antidilutive per share amount.

CONSOLIDATED STATEMENTS OF CASH FLOWS
(Dollars in thousands USD)
(unaudited)
	For the Three Months Ended March 31,
		2022			2021
Cash flows from operating activities:
Net income (loss)	$	40,592		$	(55,398	)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization		289,064			314,148
Amortization of deferred revenue and lease intangibles, net		(17,401	)		(14,766	)
Other non-cash amortization		3,109			5,272
Allowance on loans receivable and investments		(54	)		(8,902	)
Stock-based compensation		15,796			16,072
Straight-lining of rental income		(3,841	)		(3,863	)
Loss on extinguishment of debt, net		—			27,090
Gain on real estate dispositions		(2,455	)		(2,533	)
Gain on real estate loan investments		—			(74	)
Income tax (benefit) expense		(5,805	)		503
Loss from unconsolidated entities		4,269			250
Distributions from unconsolidated entities		4,356			3,897
Other		(24,324	)		(14,379	)
Changes in operating assets and liabilities:
Increase in other assets		(18,177	)		(5,100	)
Decrease in accrued interest		(13,201	)		(20,234	)
Increase (decrease) in accounts payable and other liabilities		2,625			(4,390	)
Net cash provided by operating activities		274,553			237,593
Cash flows from investing activities:
Net investment in real estate property		(343,792	)		(210	)
Investment in loans receivable		(5,117	)		(186	)
Proceeds from real estate disposals		6,124			8,083
Proceeds from loans receivable		177			16,419
Development project expenditures		(37,591	)		(58,598	)
Capital expenditures		(36,728	)		(29,674	)
Investment in unconsolidated entities		(23,790	)		(38,452	)
Insurance proceeds for property damage claims		3,391			6
Net cash used in investing activities